An explanation for these discrepancies is that in vitro culture conditions are not representative of the microenvironment experienced by cancer cells in vivo, which suggests that elevated PGC-1α expression might provide growth advantage in vivo, notably by increasing glucose uptake or by promoting the use of glutamine to support mitochondrial respiration and lipogenesis (31, 32, 50). Here, PPARGC1A is linked to cancer.